EMEA-001185-PIP01-11-M08

Table of contents

Key facts

Invented name
Rxulti
Active substance
brexpiprazole
Therapeutic area
Psychiatry
Decision number
P/0294/2022
PIP number
EMEA-001185-PIP01-11-M08
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of schizophrenia
Route(s) of administration
Oral use
Contact for public enquiries
Otsuka Pharmaceutical Development and Commercialisation Europe GmbH

E-mail: paediatric-info@otsuka-europe.com
Tel. +49 69 955 044 328

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating
Average
2 ratings